PET/CT for staging lung cancer: Costly or cost-saving?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 5, 2011, Pages 799-801

  Buck, Andreas K ^a   Herrmann, Ken ^b   Schreyögg, Jonas ^c  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL TRIAL (TOPIC); COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; ENDOBRONCHIAL ULTRASONOGRAPHY; FALSE POSITIVE RESULT; HEALTH CARE COST; HUMAN; LUNG CANCER; LUNG NODULE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; REIMBURSEMENT; REVIEW; THORACOTOMY;

CARCINOMA, NON-SMALL-CELL LUNG; COST-BENEFIT ANALYSIS; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79953723436     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-011-1803-3     Document Type: Review

References (13)

1. D Lardinois W Weder TF Hany EM Kamel S Korom B Seifert, et al. 2003 Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 25 2500 2507 12815135 10.1056/NEJMoa022136 (Pubitemid 36706537)
2. AK Buck K Herrmann T Stargardt T Dechow BJ Krause J Schreyögg 2010 Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches J Nucl Med 51 3 401 412 20150250 10.2967/jnumed.108.059584
3. MA Dinan LH Curtis BG Hammill EF Patz AP Abernethy AM Shea, et al. 2010 Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006 JAMA 303 16 1625 1631 20424253 10.1001/jama.2010.460 1:CAS:528:DC%2BC3cXlsV2lsrs%3D
4. R Søgaard BM Fischer J Mortensen L Højgaard U Lassen 2011 Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial Eur J Nucl Med Mol Imaging 10.1007/s00259-010-1703-y 21210111
5. B Fischer U Lassen J Mortensen S Larsen A Loft A Bertelsen, et al. 2009 Preoperative staging of lung cancer with combined PET-CT N Engl J Med 361 1 32 39 19571281 10.1056/NEJMoa0900043 1:CAS:528:DC%2BD1MXotVyltbo%3D
6. BS Halpern C Schiepers WA Weber TL Crawford BH Fueger ME Phelps, et al. 2005 Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion Chest 128 4 2289 2297 16236886 10.1378/chest.128.4.2289 (Pubitemid 41507571)
7. SS Shim KS Lee BT Kim MJ Chung EJ Lee J Han, et al. 2005 Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging Radiology 236 3 1011 1019 16014441 10.1148/radiol. 2363041310 (Pubitemid 41170866)
8. H van Tinteren OS Hoekstra EF Smit JH van den Bergh AJ Schreurs RA Stallaert, et al. 2002 Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Lancet 359 9315 1388 1393 11978336 10.1016/S0140-6736(02)08352-6 (Pubitemid 34442379)
9. RM Pieterman JW van Putten JJ Meuzelaar EL Mooyaart W Vaalburg GH Koëter, et al. 2000 Preoperative staging of non-small-cell lung cancer with positron-emission tomography N Engl J Med 343 4 254 261 10911007 10.1056/NEJM200007273430404 1:STN:280:DC%2BD3czltVGlsQ%3D%3D (Pubitemid 30490393)
10. M Dietlein K Weber A Gandjour D Moka P Theissen KW Lauterbach, et al. 2000 Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results Eur J Nucl Med 27 11 1598 1609 11105815 10.1007/s002590000376 1:STN:280:DC%2BD3MzgtlOjsg%3D%3D
11. F Farjah DR Flum SD Ramsey PJ Heagerty RG Symons DE Wood 2009 Multi-modality mediastinal staging for lung cancer among medicare beneficiaries J Thorac Oncol 4 3 355 363 19156000 10.1097/JTO.0b013e318197f4d9
12. FC Detterbeck MA Jantz M Wallace J Vansteenkiste GA Silvestri American College of Chest Physicians 2007 Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 3 Suppl 202S 220S 17873169 10.1378/chest.07-1362
13. J Schreyögg J Weller T Stargardt K Herrmann C Bluemel T Dechow, et al. 2010 Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer J Nucl Med 51 11 1668 1675 21051648 10.2967/jnumed.109.072090